Indonesia has already 4 SOE manufacturing pharmaceuticals. We also have around 1,000 health centres throughout the country based on the number of the population. There is also a health insurance since 2014 to cover all population at the end of this decade.
The geography of the country necessitates people in rural area to travel as far a 10km or more to seek consultation for their health. Theoretically smaller private units located in rural areas with up-to-date information system would smoothen distribution of medicines needed for these cases. Unfortunately, such undertaking cost money with funds already limited at government budget.
I would highly appreciate your comments on this problem.
Please contact my colleague Prof. Achim Schlüter, he is Economist and doing research in Indonesia.
Dear Andreas,
That is indeed a very good question. My experience was in the field of pharmaceuticals. Most of the companies are distributing through a partner firm. Could be self owned or owned by others.
I have discussed it in chapter 7 of a book by Löfgren and Williams, "The New Political Economy of Pharmaceuticals: Production, Innovation and TRIPS in the Global South" back in 2013.
SCM in Indonesia is indeed complex considering the distances in an area of around 10 mid sq km, although the archipelago is not that big.
Richard.
Thanks Mauro,
I am not sure I get your point. Do you meant strategic management as mentioned by Eisenhardt in 1989, or the one mentioned by Teece together with Pisano and Shuen in 1997 or even transient advantage by McGrath in 2013?
Richard.
- Badges
- Science method
- Similar topics
- Mathematics
- Statistics
- Statistical Techniques
- Meta-Analysis